Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Are all calcium antagonists alike?].

O Bertel1

  • 1Medizinische Klinik, Stadtspital Triemli, Zürich.

Schweizerische Rundschau Fur Medizin Praxis = Revue Suisse De Medecine Praxis
|February 11, 1992
PubMed
Summary

Calcium channel blockers vary in side effects and dosing, impacting patient compliance for hypertension. Certain types should be avoided in ischemic heart disease with reduced heart function.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Extrastriatal dopamine in symptomatic and asymptomatic rhesus monkeys treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).

Neurochemistry international·2010
Same author

Simple point-of-care risk stratification in acute coronary syndromes: the AMIS model.

Heart (British Cardiac Society)·2008
Same author

The impact of statin treatment on presentation mode and early outcomes in acute coronary syndromes.

Cardiology·2007
Same author

Quality of life and exercise capacity in patients with prolonged PQ interval and dual chamber pacemakers: a randomized comparison of permanent ventricular stimulation vs intrinsic AV conduction.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology·2004
Same author

[Acute coronary syndrome and myocardial infarct--new definitions].

Therapeutische Umschau. Revue therapeutique·2002
Same author

Rationale and perspective of endothelin-1 antagonism in acute heart failure.

Journal of cardiovascular pharmacology·2002

Area of Science:

  • Pharmacology
  • Cardiology

Context:

  • Calcium channel blockers (CCBs) exhibit diverse pharmacokinetic and pharmacodynamic profiles.
  • These differences influence hemodynamic, electrophysiological, and adverse effect profiles.
  • CCB selection for essential hypertension hinges on adverse effect rates and dosing frequency for compliance.

Purpose:

  • To elucidate the differential effects of various calcium channel blockers.
  • To guide the selection of CCBs in essential hypertension and ischemic heart disease.
  • To compare CCB efficacy in secondary prevention post-myocardial infarction.

Summary:

  • For essential hypertension, CCB choice depends on side effect profiles and once-daily dosing for compliance, as blood pressure effects are comparable.
  • In ischemic heart disease with reduced left-ventricular function, verapamil, diltiazem, and nifedipine should be avoided due to negative inotropic effects.
  • Verapamil and diltiazem are first-line for ischemic heart disease in patients with normal left-ventricular function; second-generation dihydropyridines are suitable for reduced function and combination therapy.

Impact:

  • CCBs are first-line for hypertension and ischemic heart disease treatment.
  • CCB efficacy in secondary prevention after myocardial infarction is less promising than alternatives.
  • Understanding CCB nuances is crucial for optimizing cardiovascular patient care and outcomes.

Related Experiment Videos